Established in Beverly MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 260 employees. CST is dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state antibodies utilized to expand knowledge of cell signaling pathways. Aberrant signaling within these pathways has been implicated in various diseases including cancer, diabetes and neurodegenerative diseases.

Scientists at CST follow a stringent Validation Protocol, using a combination of several approaches and applications, to provide you with the highest quality antibodies. This ensures credible and reproducible results with the least expenditure of your costly time, samples and reagents.